BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 10.14
0.00 (0.00%)
Jul 24, 2026, 5:00 PM CET
BioMaxima Financials Overview
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 59.74 | 60.9 | 52.85 | 46.79 | 143.87 | 79.09 |
Revenue Growth | 5.55% | 15.24% | 12.96% | -67.48% | 81.91% | 25.56% |
Gross Profit Gross Profit Growth | 43.58 | 31.17 | 30.14 | 24.53 | 121.26 | 57.47 |
Operating Income Operating Income Growth | 45.63 | 33.73 | 31.38 | 26.35 | 124.42 | 59.86 |
Net Income Net Income Growth | -0.16 | 0.11 | 0.54 | 0.59 | 28.89 | 10.24 |
Earnings Per Share EPS Growth | -0.09 | -0.04 | 0.01 | 0.14 | 6.59 | 2.29 |
EPS Growth | - | - | -92.86% | -97.88% | 187.77% | 23.78% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Microbiology Microbiology Growth | 39.22 | 38.61 | 30.74 | 24.63 | 24.42 | 35.9 |
Analytics Analytics Growth | 19.04 | 20.94 | 20 | 20.21 | 117.75 | 41.82 |
Others Others Growth | 1.48 | 1.36 | 2.11 | 1.95 | 1.7 | 1.37 |
Total Total Growth | 59.74 | 60.9 | 52.85 | 46.79 | 143.87 | 79.09 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 0.42 | 1.74 | 0.91 | 1.5 | 12.91 | 3 |
Total Debt Total Debt Growth | 16.18 | 14.53 | 14.7 | 12.86 | 5.83 | 17.27 |
Net Cash (Debt) Net Cash Growth | -15.75 | -12.79 | -13.79 | -11.36 | 7.08 | -14.28 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.76 | -3.05 | -3.29 | -2.63 | 1.59 | -3.18 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1.57 | 3.37 | -0.15 | 1.59 | 37.07 | -0.13 |
Capital Expenditures CapEx Growth | -0.26 | -1 | -2.27 | -18.08 | -9.88 | -4.48 |
Free Cash Flow Free Cash Flow Growth | 1.31 | 2.38 | -2.42 | -16.49 | 27.19 | -4.61 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 72.94% | 51.17% | 57.04% | 52.43% | 84.28% | 72.66% |
Operating Margin | 76.37% | 55.38% | 59.37% | 56.31% | 86.48% | 75.69% |
Pretax Margin | 78.87% | 57.90% | 61.61% | 58.60% | 87.86% | 75.39% |
Profit Margin | 78.96% | 58.03% | 61.18% | 57.75% | 92.72% | 78.59% |
FCF Margin | 2.19% | 3.90% | -4.58% | -35.24% | 18.90% | -5.83% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | - | - | - | 0.500 | 0.450 |
Dividend Per Share Growth | - | - | - | 11.11% | 80.00% |
Dividend Yield | 0.40% | 0.45% | 2.96% | 1.75% | 0.97% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 1070.00 | 117.29 | 3.90 | 11.48 |
P/FCF Ratio | 93.65 | 21.27 | - | - | 4.14 | - |
PS Ratio | 0.71 | 0.83 | 0.85 | 1.47 | 0.78 | 1.44 |